ID   MZ1879RC
AC   CVCL_X406
SY   MZ1879-RCC; MZ 1879 RC; MZ1879
DR   Wikidata; Q54907244
RX   CelloPub=CLPUB00420;
RX   PubMed=7989126;
RX   PubMed=9816317;
RX   PubMed=17200335;
RX   PubMed=12833523;
RX   PubMed=23696916;
CC   Omics: Proteome analysis by 2D-DE/MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00420;
RA   Bukur J.H.;
RT   "Characterization of T cell responses against human renal cell
RT   carcinoma and identification of HLA-G as a tumor-associated antigen
RT   and immune evasion mechanism of renal cell carcinoma.";
RL   Thesis PhD (2004); Johannes Gutenberg University Mainz; Mainz; Germany.
//
RX   PubMed=7989126; DOI=10.1002/ijc.2910590621;
RA   Bernhard H., Karbach J., Wolfel T., Busch P., Storkel S., Stockle M.,
RA   Wolfel C., Seliger B., Huber C., Meyer zum Buschenfelde K.-H.,
RA   Knuth A.;
RT   "Cellular immune response to human renal-cell carcinomas: definition
RT   of a common antigen recognized by HLA-A2-restricted cytotoxic
RT   T-lymphocyte (CTL) clones.";
RL   Int. J. Cancer 59:837-842(1994).
//
RX   PubMed=9816317;
RA   Seliger B., Hohne A., Knuth A., Bernhard H., Ehring B., Tampe R.,
RA   Huber C.;
RT   "Reduced membrane major histocompatibility complex class I density and
RT   stability in a subset of human renal cell carcinomas with low TAP and
RT   LMP expression.";
RL   Clin. Cancer Res. 2:1427-1433(1996).
//
RX   PubMed=17200335; DOI=10.1158/1078-0432.CCR-06-0824;
RA   Seliger B., Fedorushchenko A., Brenner W., Ackermann A., Atkins D.,
RA   Hanash S.M., Lichtenfels R.;
RT   "Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell
RT   carcinoma associated with enhanced tumor cell proliferation and
RT   migration.";
RL   Clin. Cancer Res. 13:27-37(2007).
//
RX   PubMed=12833523; DOI=10.1002/pmic.200300404;
RA   Seliger B., Menig M., Lichtenfels R., Atkins D., Bukur J.H.,
RA   Halder T.M., Kersten M., Harder A., Ackermann A., Beck J.,
RA   Muehlenweg B., Brenner W., Melchior S., Kellner R., Lottspeich F.;
RT   "Identification of markers for the selection of patients undergoing
RT   renal cell carcinoma-specific immunotherapy.";
RL   Proteomics 3:979-990(2003).
//
RX   PubMed=23696916; PMCID=PMC3657351;
RA   Stoehr C.G., Buettner-Herold M., Kamphausen E., Bertz S., Hartmann A.,
RA   Seliger B.;
RT   "Comparative expression profiling for human endoplasmic
RT   reticulum-resident aminopeptidases 1 and 2 in normal kidney versus
RT   distinct renal cell carcinoma subtypes.";
RL   Int. J. Clin. Exp. Pathol. 6:998-1008(2013).
//